These effects, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 help the thought of concentrating on ACKR3 as a novel technique to modulate the opioid system, which could open new therapeutic avenues for opioid-similar disorders. Disclaimer: The above mentioned is https://howardn839ogx6.activoblog.com/profile